526 related articles for article (PubMed ID: 2995967)
1. A v-erbB-related protooncogene, c-erbB-2, is distinct from the c-erbB-1/epidermal growth factor-receptor gene and is amplified in a human salivary gland adenocarcinoma.
Semba K; Kamata N; Toyoshima K; Yamamoto T
Proc Natl Acad Sci U S A; 1985 Oct; 82(19):6497-501. PubMed ID: 2995967
[TBL] [Abstract][Full Text] [Related]
2. Amplification of a novel v-erbB-related gene in a human mammary carcinoma.
King CR; Kraus MH; Aaronson SA
Science; 1985 Sep; 229(4717):974-6. PubMed ID: 2992089
[TBL] [Abstract][Full Text] [Related]
3. Amplification and enhanced expression of the epidermal growth factor receptor gene in A431 human carcinoma cells.
Merlino GT; Xu YH; Ishii S; Clark AJ; Semba K; Toyoshima K; Yamamoto T; Pastan I
Science; 1984 Apr; 224(4647):417-9. PubMed ID: 6200934
[TBL] [Abstract][Full Text] [Related]
4. Amplification and rearrangement of c-erb B proto-oncogenes in cancer of human female genital tract.
Zhang X; Silva E; Gershenson D; Hung MC
Oncogene; 1989 Aug; 4(8):985-9. PubMed ID: 2569708
[TBL] [Abstract][Full Text] [Related]
5. Amplification of c-erbB-2 oncogene in human adenocarcinomas in vivo.
Yokota J; Yamamoto T; Toyoshima K; Terada M; Sugimura T; Battifora H; Cline MJ
Lancet; 1986 Apr; 1(8484):765-7. PubMed ID: 2870269
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical study of c-erbB-2 oncoprotein overexpression in human major salivary gland carcinoma: an indicator of aggressiveness.
Sugano S; Mukai K; Tsuda H; Hirohashi S; Furuya S; Shimosato Y; Ebihara S; Takeyama I
Laryngoscope; 1992 Aug; 102(8):923-7. PubMed ID: 1353853
[TBL] [Abstract][Full Text] [Related]
7. [The erbB-related protooncogenes encoding growth factor receptors].
Yamamoto T; Toyoshima K
Gan To Kagaku Ryoho; 1987 Jun; 14(6 Pt 2):2075-82. PubMed ID: 3496852
[TBL] [Abstract][Full Text] [Related]
8. [A member of the SRC gene family, the c-erbB-1 gene, is closely related to the EGF receptor gene].
Yamamoto T; Kawai S; Toyoshima K
Gan To Kagaku Ryoho; 1985 Mar; 12(3 Pt 2):632-40. PubMed ID: 2984999
[TBL] [Abstract][Full Text] [Related]
9. [Proto-oncogene C-erbB-2 and human cancer].
Toyoshima K
Gan To Kagaku Ryoho; 1990 Mar; 17(3 Pt 1):309-14. PubMed ID: 1968737
[TBL] [Abstract][Full Text] [Related]
10. Isolation and characterization of ERBB3, a third member of the ERBB/epidermal growth factor receptor family: evidence for overexpression in a subset of human mammary tumors.
Kraus MH; Issing W; Miki T; Popescu NC; Aaronson SA
Proc Natl Acad Sci U S A; 1989 Dec; 86(23):9193-7. PubMed ID: 2687875
[TBL] [Abstract][Full Text] [Related]
11. Sequence of MET protooncogene cDNA has features characteristic of the tyrosine kinase family of growth-factor receptors.
Park M; Dean M; Kaul K; Braun MJ; Gonda MA; Vande Woude G
Proc Natl Acad Sci U S A; 1987 Sep; 84(18):6379-83. PubMed ID: 2819873
[TBL] [Abstract][Full Text] [Related]
12. Co-amplification of c-myc and c-erbB-2 oncogenes in a poorly differentiated human gastric cancer.
Tsuchiya T; Ueyama Y; Tamaoki N; Yamaguchi S; Shibuya M
Jpn J Cancer Res; 1989 Oct; 80(10):920-3. PubMed ID: 2575609
[TBL] [Abstract][Full Text] [Related]
13. A chimeric EGF-R-neu proto-oncogene allows EGF to regulate neu tyrosine kinase and cell transformation.
Lehväslaiho H; Lehtola L; Sistonen L; Alitalo K
EMBO J; 1989 Jan; 8(1):159-66. PubMed ID: 2565807
[TBL] [Abstract][Full Text] [Related]
14. Human epidermal growth factor receptor cDNA sequence and aberrant expression of the amplified gene in A431 epidermoid carcinoma cells.
Ullrich A; Coussens L; Hayflick JS; Dull TJ; Gray A; Tam AW; Lee J; Yarden Y; Libermann TA; Schlessinger J
Nature; 1984 May 31-Jun 6; 309(5967):418-25. PubMed ID: 6328312
[TBL] [Abstract][Full Text] [Related]
15. Amplification of epidermal growth factor receptor (EGFR) gene and oncogenes in human gastric carcinomas.
Yoshida K; Tsuda T; Matsumura T; Tsujino T; Hattori T; Ito H; Tahara E
Virchows Arch B Cell Pathol Incl Mol Pathol; 1989; 57(5):285-90. PubMed ID: 2570489
[TBL] [Abstract][Full Text] [Related]
16. Amplification and overexpression of the EGF receptor and c-erbB-2 proto-oncogenes in human stomach cancer.
Lemoine NR; Jain S; Silvestre F; Lopes C; Hughes CM; McLelland E; Gullick WJ; Filipe MI
Br J Cancer; 1991 Jul; 64(1):79-83. PubMed ID: 1677259
[No Abstract] [Full Text] [Related]
17. Nucleotide sequence and characterization of the 5' flanking region of the rat Ha-ras protooncogene.
Damante G; Filetti S; Rapoport B
Proc Natl Acad Sci U S A; 1987 Feb; 84(3):774-8. PubMed ID: 3027702
[TBL] [Abstract][Full Text] [Related]
18. Genetic alterations of the c-erbB-2 oncogene occur frequently in tubular adenocarcinoma of the stomach and are often accompanied by amplification of the v-erbA homologue.
Yokota J; Yamamoto T; Miyajima N; Toyoshima K; Nomura N; Sakamoto H; Yoshida T; Terada M; Sugimura T
Oncogene; 1988 Mar; 2(3):283-7. PubMed ID: 3281095
[TBL] [Abstract][Full Text] [Related]
19. Amplification, overexpression, and rearrangement of the erbB-2 protooncogene in primary human stomach carcinomas.
Park JB; Rhim JS; Park SC; Kimm SW; Kraus MH
Cancer Res; 1989 Dec; 49(23):6605-9. PubMed ID: 2573419
[TBL] [Abstract][Full Text] [Related]
20. Mechanisms involving an expanding erbB/EGF receptor family of tyrosine kinases in human neoplasia.
Di Fiore PP; Kraus MH
Cancer Treat Res; 1992; 61():139-60. PubMed ID: 1360229
[No Abstract] [Full Text] [Related]
[Next] [New Search]
